Back to User profile » Dr Michel Djandji

Papers published by Dr Michel Djandji:

Original Research

Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization

Corren J, Jackson DJ, Casale TB, Borish L, Rabe KF, Busse WW, Maspero JF, Jackson DJ, Daizadeh N, Altincatal A, Radwan A, Khodzhayev A, Djandji M, Jacob-Nara JA, Rowe PJ, Deniz Y

Journal of Asthma and Allergy 2023, 16:249-260

Published Date: 7 March 2023

Research Letter

Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation

Hanania NA, Maspero JF, Halpin DM, Jackson DJ, Panettieri RA, Castro M, Domingo C, Daizadeh N, Gall R, Jacob-Nara JA, Ortiz B, Djandji M, Rowe PJ, Deniz Y

Journal of Asthma and Allergy 2022, 15:851-854

Published Date: 28 June 2022

Original Research

Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study

Kaplan A, Chapman KR, Anees SM, Mayers I, Rochdi D, Djandji M, Préfontaine D, McIvor A

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:249-260

Published Date: 18 January 2019